logo

For the Inventor, By the Inventor

Poynton, United Kingdom

Arnold H Ratcliffe

This inventor holds 9 USPTO granted patents, plus 1 CIPO patent. Top assignee: Imperial Chemical Industries Limited. Active years: 1989-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arnold H Ratcliffe. Retrieved from https://idiyas.com/inventor/arnold-h-ratcliffe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0


Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 99(Granted Patents)


Company Filing History:

goldMedal9 out of 3,840 
 
Imperial Chemical Industries Limited
 patents

Years Active: 1989-1995

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 5380730 - Pyridine compounds which have useful pharmaceutical utility (1995-01-10),
2. 5294620 - 1,6-naphthyridinone derivatives having angiotension II antagonist (1994-03-15),
3. 5236937 - Pyridinyl compounds which are useful as angiotensin II antagonists (1993-08-17),
4. 5236936 - Pyridine compounds which are useful as angiotensin II receptor (1993-08-17),
5. 5217976 - 1,6-naphthyridone derivatives having angiotensin II antagonist activity (1993-06-08),
6. 5198439 - Angiotension II antagonizing pyridine derivatives (1993-03-30),
7. 5130318 - Angiotensin II antagonizers which are condensed pyridine derivatives (1992-07-14),
8. 5039710 - Homocyclic derivatives (1991-08-13),
9. 4803201 - Homocyclic derivatives (1989-02-07),

Title: The Innovative Contributions of Arnold H Ratcliffe

Introduction

Arnold H Ratcliffe is a notable inventor based in Poynton, GB, recognized for his significant contributions to pharmaceutical chemistry. With a total of nine patents to his name, Ratcliffe has made strides in developing compounds that address critical health conditions.

Latest Patents

Among his latest patents, Ratcliffe has developed pyridine compounds that possess useful pharmaceutical utility. These compounds are designed to treat conditions such as hypertension and congestive heart failure. The invention details the formula of these compounds and their non-toxic salts, along with pharmaceutical compositions containing them. Additionally, he has created 1,6-naphthyridinone derivatives that act as angiotensin II antagonists, further contributing to the treatment of hypertension and congestive heart failure. The processes for manufacturing these novel compounds and their applications in medical treatment are also outlined in his patents.

Career Highlights

Throughout his career, Ratcliffe has worked with prominent companies, including Imperial Chemical Industries Limited and David A. Roberts. His work in these organizations has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include Robert Hugh Bradbury and David A. Roberts, who have contributed to his innovative journey.

Conclusion

Arnold H Ratcliffe's work in pharmaceutical innovation has led to the development of valuable compounds that have the potential to improve health outcomes for many individuals. His contributions to the field are significant and continue to influence medical treatments today.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…